Kennedy, S. P., Han, J. Z. R., Portman, N., Nobis, M., Hastings, J. F., Murphy, K. J., . . . Croucher, D. R. (2019). Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast cancer research : BCR, 21(1), 43-17. https://doi.org/10.1186/s13058-019-1127-y
Citácia podle Chicago (17th ed.)Kennedy, Sean P., et al. "Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer." Breast Cancer Research : BCR 21, no. 1 (2019): 43-17. https://doi.org/10.1186/s13058-019-1127-y.
Citácia podľa MLA (8th ed.)Kennedy, Sean P., et al. "Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer." Breast Cancer Research : BCR, vol. 21, no. 1, 2019, pp. 43-17, https://doi.org/10.1186/s13058-019-1127-y.